CD44 and colorectal cancer: Research comparing colorectal cancer (CRC) xenograft derived from different percentage of EpCAM/CD44 cells discovered that EpCAMhigh/CD44+ cell group possesses the highest level of tumorigenicity (Dalerba et al., 2007).